Wuhan Anzhi Biotechnology Center (sole proprietorship) – Trademark Portfolio
Entity Type: 19
Wuhan Anzhi Biotechnology Center (sole proprietorship) holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ORGANI HERBENCE. The owner is based in Wuhan City, Hubei Province.
Room 10784, 1F, No. 1588, Gutian 2nd Road, Qiaokou District
Wuhan City, Hubei Province 430035 , CN
Showing of trademarks Trademarks
Trademark Classifications
Wuhan Anzhi Biotechnology Center (sole proprietorship)'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Wuhan Anzhi Biotechnology Center (sole proprietorship) have?
Wuhan Anzhi Biotechnology Center (sole proprietorship) has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Wuhan Anzhi Biotechnology Center (sole proprietorship) file in?
Wuhan Anzhi Biotechnology Center (sole proprietorship) files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Wuhan Anzhi Biotechnology Center (sole proprietorship)'s most well-known trademarks?
Wuhan Anzhi Biotechnology Center (sole proprietorship)'s registered trademark portfolio includes well-known marks such as ORGANI HERBENCE. These are among 1 currently registered trademark in the portfolio.
What is Wuhan Anzhi Biotechnology Center (sole proprietorship)'s trademark registration success rate?
Wuhan Anzhi Biotechnology Center (sole proprietorship) has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.